Search: id:"swepub:oai:DiVA.org:oru-74426" >
Homocysteine Status...
-
Jernerén, FredrikUppsala universitet,Institutionen för farmaceutisk biovetenskap
(author)
Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease : The OmegAD Study
- Article/chapterEnglish2019
Publisher, publication year, extent ...
-
IOS Press,2019
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:oru-74426
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-74426URI
-
https://doi.org/10.3233/JAD-181148DOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-384475URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:140849022URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Funding Agencies:Funds of CapioSwedish Alzheimer Foundation Norwegian Research Council Odd Fellows Swedish Society of Physicians Lion's Sweden
-
Background: Trials of supplementation with omega-3 fatty acids (omega 3-FAs) in patients with mild cognitive impairment or Alzheimer's disease (AD) have produced inconsistent effects on cognitive decline. There is evidence of an interaction between B vitamin status and omega 3-FAs in relation to brain atrophy and cognitive decline.Objective: We investigated whether baseline levels of plasma total homocysteine (tHcy), a marker of B vitamin status, modify the effects of omega 3-FAs supplementation on cognitive performance in moderate AD.Methods: This post hoc analysis of the OmegAD trial included 171 community-based patients with AD (MMSE >= 15): 88 patients received daily doses of 1.7 g docosahexaenoic acid and 0.6 g eicosapentaenoic acid for 6 months. Treatment outcome on cognition was analyzed according to baseline levels of tHcy using a general linear model and ANCOVA.Results: We found significant interactions between omega 3-FA supplementation and tHcy on cognition and clinical stage assessed by MMSE (p = 0.040), global CDR (p = 0.059), and CDRsob (p = 0.023), but not on ADAS-cog (p = 0.649). In patients with tHcy levels <11.7 mu mol/L, omega 3-FA supplementation improved cognitive performance as measured by MMSE (+7.1%, 95% CI: 0.59 to 13.7%, p = 0.033) and clinical status as measured by CDRsob (-22.3%, 95% CI: -5.8 to -38.7%, p = 0.009) compared with placebo.Conclusion: The effect of omega 3-FA supplementation on MMSE and CDR appears to be influenced by baseline tHcy, suggesting that adequate B vitamin status is required to obtain beneficial effects of omega 3-FA on cognition.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Cederholm, TommyKarolinska Institutet,Uppsala universitet,Geriatrik,Karolinska Univ Hosp, Theme Ageing, Stockholm, Sweden(Swepub:uu)tomce419
(author)
-
Refsum, HelgaDepartment of Nutrition, University of Oslo, Oslo, Norway; Department of Pharmacology, University of Oxford, Oxford, United Kingdom,Univ Oslo, Dept Nutr, Oslo, Norway;Univ Oxford, Dept Pharmacol, Oxford, England
(author)
-
Smith, A. DavidDepartment of Pharmacology, University of Oxford, Oxford, United Kingdom,Univ Oxford, Dept Pharmacol, Oxford, England
(author)
-
Turner, CherylDepartment of Pharmacology, University of Oxford, Oxford, United Kingdom,Univ Oxford, Dept Pharmacol, Oxford, England
(author)
-
Palmblad, JanKarolinska Institutet
(author)
-
Eriksdotter, MariaKarolinska Institutet
(author)
-
Hjorth, ErikKarolinska Institutet
(author)
-
Faxen-Irving, GerdKarolinska Institutet
(author)
-
Wahlund, Lars-OlofKarolinska Institutet
(author)
-
Schultzberg, MarianneKarolinska Institutet
(author)
-
Basun, HansUppsala universitet,Geriatrik(Swepub:uu)habas169
(author)
-
Freund-Levi, Yvonne,1956-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden; Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Huddinge, Sweden; Department of Psychiatry in Region Örebro County and School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro; Department of Old Age Psychiatry, Psychology & Neuroscience, King’s College, London, UK,Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden;Karolinska Inst, Ctr Alzheimer Res, Div Clin Geriatr, Huddinge, Sweden;Orebro Univ, Dept Psychiat Reg Orebro Cty, Fac Med & Hlth, Orebro, Sweden;Orebro Univ, Sch Med Sci, Fac Med & Hlth, Orebro, Sweden;Kings Coll London, Dept Old Age Psychiat Psychol & Neurosci, London, England(Swepub:oru)yfi
(author)
-
Uppsala universitetInstitutionen för farmaceutisk biovetenskap
(creator_code:org_t)
Related titles
-
In:Journal of Alzheimer's Disease: IOS Press69:1, s. 189-1971387-28771875-8908
Internet link
Find in a library
To the university's database
- By the author/editor
-
Jernerén, Fredri ...
-
Cederholm, Tommy
-
Refsum, Helga
-
Smith, A. David
-
Turner, Cheryl
-
Palmblad, Jan
-
show more...
-
Eriksdotter, Mar ...
-
Hjorth, Erik
-
Faxen-Irving, Ge ...
-
Wahlund, Lars-Ol ...
-
Schultzberg, Mar ...
-
Basun, Hans
-
Freund-Levi, Yvo ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Neurology
- Articles in the publication
-
Journal of Alzhe ...
- By the university
-
Örebro University
-
Uppsala University
-
Karolinska Institutet